Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Ayurvedic herbs may reduce side effects and improve effectiveness of cancer treatments.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.